Psychiatry & Neurology Doctors in High Point, NC Accepting Medicare

24 Psychiatry & Neurology doctors found. Showing 21 - 24

William Francis Spillane, MD Psychiatry & Neurology - Pain Medicine Medicare: Medicare Enrolled Practice Location: 606 N Elm St, High Point, NC 27262 Phone: 336-889-8877    Fax: 336-889-7832

Dr. Marica Bijelac, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 211 S Centennial St, High Point, NC 27260 Phone: 336-899-1505    Fax: 336-899-1513

Mr. Miles Edward Dewayne Hairston Sr., DNP Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 601 N Elm St, High Point, NC 27262 Phone: 336-878-6000

Edward Willis Love Jr., MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 320 Boulevard St, High Point, NC 27262 Phone: 336-878-6226    Fax: 336-878-6272

News Archive

Study: Medicaid patients' health could impact health law's bottom line

The New York Times reports on a news study concluding that Medicaid surgery patients ultimately cost more than those on private insurance - a finding that may foreshadow what happens as the Medicaid rolls grow under the health law.

Yoweri Kaguta Museveni has caused a major divide among participants of the AIDS Conference in Thailand

The president of Uganda, Yoweri Kaguta Museveni has caused a major divide among participants at the 15th International AIDS Conference in Thailand by stating that abstinence and marriage are the best ways to stop the spread of the HIV/AIDS epidemic.

Epilepsy Foundation Northwest adds Alaska to territory

The Epilepsy Foundation Northwest (EFNW) announced the addition of Alaska to its affiliate, making it the largest territory in the nation for the Epilepsy Foundation organization. Programs and services provided by EFNW for people living with epilepsy and their families will now officially include Alaska.

EC grants Allos Therapeutics' pralatrexate orphan medicinal product designation for CTCL treatment

Allos Therapeutics, Inc. announced today that the European Commission (EC) has granted orphan medicinal product designation for pralatrexate for the treatment of cutaneous T-cell lymphoma (CTCL). The Company is currently investigating pralatrexate in a Phase 1 clinical study in patients with relapsed or refractory CTCL.

A roadmap for critical care societies to address burnout among health care professionals

A new paper published online in the Annals of the American Thoracic Society provides a roadmap that critical care clinicians' professional societies can use to address burnout.

Read more Medical News

› Verified 3 days ago

• 1
• 2(current)